OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
SoundBite Communications (NASDAQ: SDBT) went from a relatively obscure company that attracted little attention from investors to one of the biggest movers on Tuesday following news that the Board of Directors had unanimously approved a definitive agreement to be acquired … Continue reading →
Less than a month ago shares of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) were trading at a 52-week high of 7.67 following news that the FDA had approved their nephropathic cystinosis drug, Procysbi, a twice-daily oral medication that puts it in … Continue reading →
Shares of Camtek Ltd. (NASDAQ: CAMT) spiked to a 52-week high of 2.65 on Monday following the release of the company’s first quarter 2013 financial results which showed an improvement in revenue from their fourth quarter 2012 while forecasting an … Continue reading →
While it has been more than a week since Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) released their first quarter financial and operational results it was today that the biopharmaceutical company focused on the development and commercialization of products for the treatment … Continue reading →
The response to yesterday’s release of first quarter results for Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) has been overwhelmingly positive as the company, which is a leading global owner of Supramax dry bulk vessels that range in size from 50,000 … Continue reading →
Almost one year ago shares of Rockwell Medical, Inc. (NASDAQ: RMTI) were trading as high as 10.70 but those days must seem like a distant memory for the fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease … Continue reading →
Alimera Sciences, Inc. (NASDAQ: ALIM) surged to a 52-week high of 3.98 on Monday, this after closing Friday’s trading session at 3.11, while volume in the biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals … Continue reading →
Posted in Articles, NASDAQ
|
Tagged alim, alimera sciences, biopharmaceutical, diabetes, diabetic, dme, fda, iluvien, investors, pdufa
|
Just over a week ago shares of Unilife Corporation (NASDAQ: UNIS) sank to a 52-week low of 1.80 and the future of the developer and supplier of injectable drug delivery systems was less than certain but the company has seen … Continue reading →
While shares of Groupon, Inc. (NASDAQ: GRPN) remain well below their 52-week high of 14.93, set nearly a year ago, the company does appear to be heading in the right direction following yesterday’s first quarter 2013 results. Following the release … Continue reading →
After announcing the initial phase of a multi-million dollar, multi-year deal with a Tier 1 Asian operator shares of RADCOM Ltd. (NASDAQ: RDCM) shot through the roof on Friday, climbing as high as 4.80 and challenging their 52-week high of … Continue reading →
